Urinary Catheters Often Left in Too Long During Hospital Stay

Share this content:
Urinary Catheters Often Left in Too Long During Hospital Stay
Urinary Catheters Often Left in Too Long During Hospital Stay

(HealthDay News) -- Even when appropriately used, urinary catheters are often left in place longer than necessary in hospitalized patients, according to a perspective piece published online Dec. 15 in JAMA Internal Medicine.

Mahmood Al-Abri, M.D., of the University of Toronto, and colleagues published a case report describing complications related to prolonged use of a urinary catheter during the hospitalization of an elderly man with cognitive impairment.

According to the authors, an elderly man in his 80s, with a history of cognitive impairment, was admitted to the hospital with septic shock, thought to be secondary to pyelonephritis. A urinary catheter was inserted in the emergency department, and the patient initially had no urine output. Following six hours of intravenous fluids, urine output increased, and the patient was admitted to a general medical unit. By the morning of the second day, the patient's condition had responded to medical treatment, and his hemodynamic status had improved; intravenous fluids were discontinued. That night, the patient awoke in a delirious state and pulled out his urinary catheter. The patient had profuse gross hematuria and required several additional days of hospitalization and medical treatment for this trauma. The additional day of catheterization following discontinuation of intravenous fluids may have contributed to the development of delirium and then resulted in the further complication of urethral injury in this patient.

"Urinary catheter use, even for appropriate indications, is often unnecessarily prolonged among hospitalized patients," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »